AFR article this afternoon with comments from IGO MD assessing M&A after their PAN bid lapsed. ‘Assessing a number of opportunities... assets in production and others at development stage..
Main focus Ni & Co but doesn’t rule out diversifying into others incl Li, rare earths etc.
Interesting how they’re thinking about their MCR stake.
